🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Claudio Russolo

1 post
Cambrex has started construction on a $120 million expansion of its Charles City pharmaceutical manufacturing facility in Iowa, targeting additional active pharmaceutical ingredient and synthetic peptide production capacity by late 2028.
Read More

Cambrex begins $120m Iowa API expansion, but can new peptide capacity deliver commercial returns by 2028?

Cambrex has broken ground on its $120 million Charles City expansion, adding 160,000 litres of capacity for small molecule active pharmaceutical ingredients and synthetic peptides. The project advances a previously announced investment, supported by state incentives and employment commitments, but manufacturing qualification and commercial utilisation will determine its eventual economic contribution.